Stroke & Cerebrovascular Diseases


Investigators

  Reza Behrouz, D.O.

  Lee Birnbaum, M.D.

  Christopher Topel, D.O.

Research Studies

  • A Phase III, Prospective, Double Blind, Randomized, Placebo-Controlled Trial of Thrombolysis in Imaging-Eligible, Late Window Patients to Assess the Efficacy and Safety of Tenecteplase (TIMELESS)
  • A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects with Disability Following an Ischemic Stroke (PISCES III)
  • AtRial Cardiopathy and Antithrombotic Drugs in prevention After cryptogenic stroke (ARCADIA)
  • Effect of treatment on cognition and silent infarcts (ARCADIA-CSI)
  • Efficient Resource Utilization for Patients with Intracerebral Hemorrhage (EnRICH)
  • Lone Star Stroke Consortium TeleStroke Registry (LESTER)
  • Longitudinal Study of Young Patients with Embolic Stroke of Undetermined Source (YESUS)
  • Optimal Delay Time to Initiate Anticoagulation after Ischemic Stroke in Atrial Fibrillation (START)

Publications

Kristen B. Slaughter, Meyer EG, Bambhroliya AB, Meeks JR, Ahmed W, Bowry R, Behrouz R, Mir O, Begley C, Tyson JE ,Miller C, Warach S,  Grotta JC, McCullough LD, Savitz SI, Vahidy FS. Direct Assessment of Health Utilities Using the Standard Gamble Among Patients With Primary Intracerebral Hemorrhage. Circulation: Cardiovascular Quality and Outcomes. 2019;14:9. DOI: 10.1161/CIRCOUTCOMES.119.005605.